Dexcom shares fall more than 40% after second-quarter results
Dexcom Shares fell more than 40% on Friday and were on track for their worst day ever after the diabetes…
Dexcom Inc.
A poor earnings report from a competitor is good news for Abbott Labs
Every weekday, the CNBC Investment Club with Jim Cramer hosts a live “Morning Meeting” broadcast at 10:20 a.m. ET. Here’s…
Dexcom shares fall more than 30% after the company lowered its fiscal year forecasts
The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Lightrocket…
Abbott receives FDA approval for Libre Rio and Lingo
Abbott Chairman and CEO Robert B. Ford delivers a keynote speech at CES 2022 at The Venetian Las Vegas on…
Dexcom announces that Stelo has been approved by the FDA
The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Light…
Citi and others are bullish on biotech, medtech and more
2023 was not a good year for the healthcare sector, but some investors expect it to return this year, highlighting…